DatasetName,MBP_S(14) MBP_S(16) MBP_S(19) MBP_S(26) MBP_S(285) MBP_S(3) MBP_S(36) MBP_S(40) MBP_S(96) MBP_T(154) MBP_T(21) MBP_T(4),MBP_S(146) MBP_S(153) MBP_S(205) MBP_S(249) MBP_S(299) MBP_S(6) MBP_S(9) MBP_T(229) MBP_T(283) MBP_T(7),MBP_S(112) MBP_S(266) MBP_S(59) MBP_T(106) MBP_T(232)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.5251610284599653,,
FSO2013_Ratio M/L normalized Rep3,0.536163330997234,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,0.5320925246524061,,
RCJD2014_15min_1,0.5341540529326899,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,0.4191818729334729
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,0.47048331729976783
FSO2013_Ratio M/L normalized Rep1,0.5455001061557235,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5482634815820792,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.5299333353168576,,0.4315679379549927
DB2022_Intensity L2,0.5160038332379334,0.6297504620700137,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,0.5276472231313202,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.5128397438847639,,
RB2022_5_PreEndurance,0.5219476516622913,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5182653619831965,,
EP2017_Untreated R#4 normalized log2 ratio,,,
WZ2023_Pu_010_30min,,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,0.526434812790839,,
KBE2022_Log2_Ex_14_U,0.5150723843549906,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,0.5317174178370018,,
PG2020_Intensity 8h_C,0.5314422770061721,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,0.5258039564257796,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5177822084394831,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,0.5467758567668798,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.5082900639011587,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5194708162361592,,
GF2025_P6_Sph,0.525200438886968,,
RB2022_2_PreSprint,0.5258657333831348,,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.5271022872035386,,0.44205898657875553
WZ2023_Pu_005_10min,,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5330537869060404,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,,,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.5161537378195543,,0.42240292776795957
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.5499875512314537,,
EJN2021_3_Rest_Basal,0.5174986664232488,,0.42527522582664146
CR2017_Ratio Replicate 1.3,0.5087855803714226,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,0.4080448349348666
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5306924228183142,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5226322986399562,,0.4449564849593187
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,,,
CK2022_11 40-1,0.5347297930609876,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.5474896143865311,,
WZ2023_Pu_005_20min,,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.526098518782865,,0.4256859263363727
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.5160445077240384,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,0.5344890550079845,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,0.5014563433664477,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,0.5332263956540635,0.6534249567542754,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,0.43774073629644733
CK2022_1 200-1,0.506042269353549,,0.426592384822072
PG2020_Intensity Mock_10h_D,0.523399773966494,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.5225747145780485,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,
RCJD2014_5min_1,0.5409346203987145,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5247866258616064,,
PG2020_Intensity 2h_C,0.5299930496299382,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,0.5205346057242896,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.5287889108841631,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.5167582835957722,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,0.5153318875338678,,0.4193030581450087
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.5202694007810157,,
RB2022_1_PostEndurance,0.5121323384483389,,
CR2017_Ratio Replicate 3,0.5156334146217393,,0.45606251288091315
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5141097113556876,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5346197539643462,,
HS2024_8_I_T3,,,
CF2017_EOC 3,0.5202927903378801,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.5341660612574931,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5169378907107659,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,0.41470364760623146
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,0.5328304042573638,,
RB2022_5_RecoveryEndurance,0.5224354557960968,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,0.5445552319601044,,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.5246542726069384,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.5330823247680184,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5235459690705236,,0.44219510899592207
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5168748458887967,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.5443892265980984,,0.4364752879844601
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,0.422335220105731
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5313106825642776,0.6405396200690878,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5128732696732037,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.5158580730972177,,
FSO2013_Ratio M/L normalized Rep2,0.5586094993174088,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.5178555042417848,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.543627250200413,,
RB2022_6_PreSprint,0.5244129297037848,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.4822535784972066,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,0.5181986794165611,,0.4145157273837546
RN2012_H05,0.5180622046330533,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.523667167883386,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.5291783025521788,,
EJN2021_1_Rest_Ins,0.5034014837519699,,0.4277677492430293
HH2022_Reporter intensity 3,0.5277439064226191,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,0.5172693676021617,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.5322262545489982,,0.4507301211990936
CK2022_12 200-1,0.5331813041651075,,0.4419478035620932
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5205257431585224,,
WZ2023_Su_010_20min,,,
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.5278216567197501,,0.43856971906946507
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5121948143323074,0.6282381703018454,
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.5317359779349119,,
CK2022_14 200-1,0.5370537667472625,,0.4437116434621389
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.5459194038280817,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,0.5291516619188547,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5166095085040618,,0.4521824153254185
SR2019_LM2_Biol_repl_4,0.5264019422590859,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,0.42912489558202527
GF2025_P1_Adh,0.5341817636516036,,
GF2025_P1_Sph,0.501566936115285,,
EJN2021_5_Ex_Basal,0.5121295848306882,,0.4355638645405565
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,,,
CF2017_EOC 1,0.5116875601759151,,
CK2022_3 200-1,0.5058454734849032,,0.42927951128047237
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,0.524216606779312,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.521273092975839,,
CK2022_2 40-1,0.517018509054203,,
RB2022_1_PostSprint,0.5261775366529617,,
CK2022_4 200-1,0.5065893108453313,,0.43209408430955126
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,0.4182335373041551
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.5147104973713872,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,0.5256021843499328,,
CR2017_Ratio Replicate 3.2,0.5421055029553347,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.510444169146011,,
CK2022_9 16-1,,,0.47109752380205555
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,0.48045723419320063
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5370559564105389,,0.4373092518706039
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.5091065164964251,,0.42605933121101236
CK2022_16 16-1,,,0.42087180735222096
FS2019_db/db3,,,
CK2022_15 40-1,0.5437388749126895,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5310823598186661,,0.43816040492658503
AMK2021_Ctrl_p1,,,0.44170153812995006
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.5157373376207022,,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.5485257830653961,,0.43696117765173365
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.5189297204419784,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.5183845145642668,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.5271576039478919,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,0.45143798386756917
RN2012_L13,0.5264946450089143,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.5520208243340696,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5308256664361041,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.5328087063543832,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5265560389540477,,
HH2022_Reporter intensity 6,0.520594835740463,,
RB2022_2_RecoveryStrength,0.5195908080075757,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,0.5628198700358982,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5096428576778139,,
KBE2022_Log2_Ex_19_U,0.5131990120906795,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5163264498918864,,
RB2022_4_PostStrength,0.5223559102415861,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,0.5154859648404598,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.5141315324547967,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5320552387642307,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5172066744421792,,
RB2022_7_RecoverySprint,0.5182857096885173,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,0.5272167535347155,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,0.5275800637456057,,
HH2022_Reporter intensity 2,0.5279897346148541,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,0.526103904917045,,
EP2017_Untreated R#2 log2 ratio,,,
SR2019_LM2_Biol_repl_3,0.5277802493383784,,
RB2022_4_RecoveryStrength,0.5202179011963463,,
CR2017_Ratio Replicate 2,0.5096175896967933,,0.43638883665535894
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5386983040957937,,
AR2021_KD 72h,0.528672483814621,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5273380433440604,,0.4305600339925776
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,0.5020732558929077,,0.4382746614109034
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.5136970909604369,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,0.5227894546055193,,
CF2017_OSE 29,0.523634642140114,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.51489711572322,,
RN2012_L12,0.5338707622688491,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5290670255646498,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5167804996549538,,
RB2022_7_RecoveryEndurance,0.5111708959440175,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5129768586224503,,0.44128111836746714
TM2022_S2.12h.B,,,
RN2012_L15,0.5194076931036773,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.5320721339048378,,
FSO2013_Ratio H/M normalized Rep2___2,0.5401334511465858,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.5303297246883862,,0.43487315013230604
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,0.5010968943193059,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.5041132782692933,,0.42592441139886256
CK2022_5 200-1,0.5026951860249116,,0.42247054240246174
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.5142776636770816,,
FSO2013_Ratio H/L normalized Rep2___1,0.5236598930899224,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.5266747423606647,,0.4316896112867939
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.5236992009324014,,0.4298567769809716
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,0.5256429243289188,,
DB2022_LFQ intensity L2.1,0.5354850694882182,0.6100669461675226,
FSO2013_Ratio H/M normalized Rep1,0.5393591796819049,,
CK2022_4 16-1,,,0.44345416126303083
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.502849919508087,,0.4475621619402519
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.5154504750898169,,0.4418043618468321
FSO2013_Ratio H/L normalized Rep3,0.5125280782299549,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.5069887231097351,,0.43658982270240365
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5053292251055524,,
WZ2023_Pe_025_20min,,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,,,
RN2012_H06,0.5271001723705971,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,,,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5125725472017354,,0.42323584991347063
WZ2023_Su_025_10min,,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,0.5211657032184591,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.530518370096128,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,,,
RN2012_L10,,,
PG2020_Intensity 4h_C,0.5316300743127141,,
EP2017_Mitotic R#3 normalized log2 ratio,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,0.5315949152571025,0.6006828412158113,
KBE2022_Log2_Ex_24_T,0.5308620412217419,,0.4374859583130732
RB2022_8_PostStrength,0.5164658236484727,,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.5351201767992146,,0.440940782348882
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.5322644437903318,,
CR2017_Ratio Replicate 1.1,0.5212161086029182,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.5192429937996101,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5379690538014138,,0.45608473666520155
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,
GF2025_P9_Sph,0.5300920895124038,,
CK2022_6 200-1,0.5036599239661234,,0.42609282469603416
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,0.5319965919787247,0.6259799161341738,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.5184076848367417,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.5215306385970558,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,0.5275317387258415,,
EP2017_Untreated R#3 normalized log2 ratio,,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5038539972846219,,0.44800087477881945
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.5127417912677583,,0.4269317527599362
RB2022_7_PostEndurance,0.514106810768997,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,0.5153485520834438,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.5258063075236135,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.5131319868808395,,0.4337624740594495
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,0.43618862116846097
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5086138031628279,,0.4346711561459104
FR2021_Intensity.M,,,
RB2022_2_PostSprint,0.5260489248211961,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.5153898857545315,,
PG2020_Intensity CT_C,0.5281550610510765,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5246165965008222,,0.4340294201679882
EP2017_Untreated R#3 log2 ratio,,,
RB2022_2_PostStrength,0.5206978237501635,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5159333068537091,,0.43730380082546755
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.5306864097481901,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5166333147426295,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5369117327158631,,0.42864599171083845
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.5265315064495828,,
CR2017_Ratio Replicate 2.3,0.5409744956138146,,0.44592904666305155
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5628280413285641,,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,0.4428560305535233
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.5078108029607165,,
CK2022_2 16-1,,,0.43479928395875966
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.5424886107653754,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5158861142494572,,0.4364724594782783
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,0.524625249695945,,
WZ2023_Su_025_30min,,,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5146779875312869,,0.4241037195017439
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.5230509249862837,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,0.4474429423573826
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.5210584280709148,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,0.5335110446040287,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,0.5163365157236646,0.6372346282087054,
GF2025_P6_Adh,0.4911135881260897,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,0.5302003822870859,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.5229262511566461,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.5290422798876863,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,0.5227185741205275,,
GF2025_P9_Adh,0.49158858638154035,,
RB2022_3_PostStrength,0.5284551274780648,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.532466946356141,,0.3941290694536642
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,0.5308368054788146,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.521476825771458,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.5571515684578064,,
DB2022_LFQ intensity L2,0.5337632018732708,0.6478138033467055,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.554398443482928,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5243056527261868,0.622195185035683,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.526666504707853,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.5235139387329669,,0.46803400927022737
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5076986174637385,,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,0.546007744927837,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,0.5250658949084411,,
RB2022_1_RecoverySprint,0.5242654760361228,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.514635534377712,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5164774635686055,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.5341217254933066,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,0.6570025940038666,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.5263915391785421,,
FSO2013_Ratio H/L normalized Rep1,0.553202367160979,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.5156050562889213,,
CK2022_13 40-1,0.5440891796204832,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,0.5109606951670645,,
RB2022_8_PreEndurance,0.5284150481339326,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.5031088319604046,,0.43703732028696435
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.4950132219494599,,0.4379824875751141
EP2017_Pervanadate R#3 log2 ratio,,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,0.5110597828693829,,
RB2022_6_PostStrength,0.5221811198751074,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,0.5322349097337341,0.5990900779185909,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.515792744500536,,
RN2012_H04,0.5190088682535823,,
CK2022_6 40-1,0.5167001075550434,,
DB2022_LFQ intensity R2.1,0.5000884396717716,0.6651872714528555,
KBE2022_Log2_Ex_42_U,0.5358618383919412,,0.44374195330427535
LY2019_P3-,0.5420343532928569,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.5155067746036874,,0.43771230771769076
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,,,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.5125398631285737,,0.43755086130381926
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,0.5277238104363533,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.49451949664005784,,
RB2022_1_RecoveryStrength,0.5297112026920955,,
SR2019_HCC1954_Biol_repl_4,0.5126006623539215,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,0.5295509015607259,,
DB2022_Intensity R2,0.5172761587169418,0.6616578397892348,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,0.5273342175565437,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,0.54020508984473,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5257145331115884,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5167694975077802,0.6396102441122913,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5209275634636658,,0.4413587265220169
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.5298439182240017,,
LY2019_P2-,0.5116824876267112,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,,,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,0.5105476569149373,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5171317116437503,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.5334553057433679,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5409338769316224,,0.4362174809062663
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,
KBE2022_Log2_Ex_36_T,0.5349008227475737,,0.4374437562530088
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,,,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,0.5488585344000768,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5252220428347281,,0.4398948486897332
CK2022_9 200-1,0.531113579497609,,0.45131729035657875
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,0.5336148861349331,0.6311663915687398,
CK2022_10 200-1,0.530007729306732,,0.45351438358278273
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5376009806861701,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5122112106988064,,0.4356050916528127
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.5152518870719228,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,0.5039646004050593,,0.4370363902562727
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5218776070527511,,0.4291238609718587
FSO2013_Ratio H/M normalized Rep3___2,0.5394882469199013,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5199885632449556,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.519768254237461,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.5343502072189897,,
PG2020_Intensity 2h_A,0.5307201420579983,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,0.5296563517598791,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5165497410887566,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.5137897005556007,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.5219561087678307,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,0.5267718216972282,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,0.5234161869858605,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,,,
KBE2022_Log2_Ex_29_U,0.5158771259683018,,0.4305949894400049
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.5373932919556003,,0.4351090587799494
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5290082136130503,,0.44548377343571727
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.516961494085355,,
LY2019_P2+,0.5082671001938944,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.5323250199736466,,
CK2022_2 200-1,0.5077022823252272,,0.4285120453743496
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,,,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.5142234191926137,,0.4476050692792672
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,0.5288549634361795,,0.43340688356897505
WZ2023_Pe_010_20min,,,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,0.5060864336604955,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,0.5238286563963689,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.52147386370058,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5349576247105393,,0.42876568943435267
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,,,
PG2020_Intensity 6h_C,0.5157579798311341,,0.41371369505492905
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,,,0.42385370507127484
CK2022_3 16-1,,,0.4381665785442593
LY2019_P4-,0.5261319800936838,,
FSO2013_Ratio H/L normalized Rep3___2,0.5202717691523772,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.5042974441179757,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5073516789254676,,
CK2022_10 16-1,,,0.47229147052638776
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5350352624912149,0.6351738296986301,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,0.4582726312833826
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,0.5053915334345095,0.6103754222862579,
DB2022_Intensity R1,0.5319140167249673,0.6685330221774904,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,0.5350118703984599,0.606931655427606,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,
EJN2021_2_Ex_Basal,0.514929634459224,,0.44399577904750487
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,0.5169482799798082,,
CF2017_FTE 16,0.5182926519111235,,
AR2021_L41 10 μM,,,
CF2017_EOC 2,0.5153454181727161,,
RB2022_6_PostEndurance,0.5273084094158355,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,0.5466364956215978,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,,0.41496031371650616
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.5280372394000631,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.5283870258302773,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5077819158947635,,0.4347646913797294
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,0.5333501447879366,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,0.43198591548838755
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.5280284455477497,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.5209910522134564,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,0.54064524945963,,
FSO2013_Ratio M/L normalized Rep3___1,0.5270185209128176,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.5094135995496758,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5348540958741616,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.544331608839112,,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,0.5141466536836247,,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,,,
GF2025_P5_Adh,0.5173041469217645,,
RB2022_1_PostStrength,0.5185356720221647,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5182001100105135,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.5073810341387008,,0.4237190663498073
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,0.46987355616853366
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5230497317373319,,0.4478252711284827
PG2020_Intensity CT_B,0.526028784164979,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,0.5401125157392342,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,0.4280963263841768
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.555110211100258,,
RB2022_2_PreEndurance,0.5309769450162741,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.5264996765506815,,0.4334705127066999
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,0.42199255163055316
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5461677047319567,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,0.5088341332383769,,
FSO2013_Ratio H/M normalized Rep1___2,0.5360599797282459,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.509490692080673,,0.44826871903350024
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,0.5475156109657738,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.5294082749353365,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,0.516632164902335,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,0.5204282876176981,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.5086979414572057,,0.4132570257447221
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.531601012304231,,
EP2017_Untreated R#2 normalized log2 ratio,,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,0.5310785501051104,0.6255247289742722,
LY2019_P5+,,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
